Aquinox Skyrockets 955% In 2 Days Amid Drug News
Tiny Aquinox Pharmaceuticals on Monday had a trading day that was crazy even by biotech standards, halted twice by the Nasdaq due to volatility as it soared more than fivefold to a peak of 55.75, ending the day up a mere 81%, at 18.88. That’s on top of a 482% gain on Friday, bringing the two-day stock advance to 955%. The stock closed Thursday at 1.79. The trigger was Aquinox’s (AQXP) positive midstage trial results for AQX-1125, its only